Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1975 1
1976 1
1977 3
1978 3
1979 1
1980 1
1984 3
1995 2
1997 2
1998 4
1999 1
2001 1
2005 1
2007 1
2010 3
2012 1
2013 2
2014 1
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial.
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E; PIONEER 8 Investigators. Zinman B, et al. Diabetes Care. 2019 Dec;42(12):2262-2271. doi: 10.2337/dc19-0898. Epub 2019 Sep 17. Diabetes Care. 2019. PMID: 31530667 Free PMC article. Clinical Trial.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Primary aldosteronism.
Litchfield WR, Dluhy RG. Litchfield WR, et al. Endocrinol Metab Clin North Am. 1995 Sep;24(3):593-612. Endocrinol Metab Clin North Am. 1995. PMID: 8575411
An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I, Bunting M, Fenix K, Haylock-Jacobs S, Litchfield W, Harata-Lee Y, Turvey M, Brazzatti J, Gregor C, Nguyen P, Kara E, McColl SR. Comerford I, et al. Among authors: litchfield w. Bioessays. 2010 Dec;32(12):1067-76. doi: 10.1002/bies.201000063. Epub 2010 Oct 15. Bioessays. 2010. PMID: 20954179 Review.
Regulation of chemotactic networks by 'atypical' receptors.
Comerford I, Litchfield W, Harata-Lee Y, Nibbs RJ, McColl SR. Comerford I, et al. Among authors: litchfield w. Bioessays. 2007 Mar;29(3):237-47. doi: 10.1002/bies.20537. Bioessays. 2007. PMID: 17295321 Review.
Glucocorticoid-remediable aldosteronism.
Litchfield WR, Dluhy RG, Lifton RP, Rich GM. Litchfield WR, et al. Compr Ther. 1995 Oct;21(10):553-8. Compr Ther. 1995. PMID: 8565422 Review.
The bittersweet demise of Herod the Great.
Litchfield WR. Litchfield WR. J R Soc Med. 1998 May;91(5):283-4. doi: 10.1177/014107689809100513. J R Soc Med. 1998. PMID: 9764087 Free PMC article. No abstract available.
37 results